PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

PCI Pharma Services Appoints New Chief Financial Officer, SVP, Serge Dupuis

Philadelphia, PA – 22 March, 2019. Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer (CFO).

Serge’s appointment supports PCI’s continued strategic growth and expansion across its global network, currently spanning 20 facilities in eight locations across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.

Serge brings to PCI more than 20 years’ experience in senior leadership roles, mainly in manufacturing environments. He joins the organization from CSP Technologies where he held the role of CFO. Prior to this, Serge served in significant senior-level roles with a range of internationally-recognized manufacturing and services, logistics and defense companies.

In welcoming Serge to PCI, Chief Executive Officer Salim Haffar said: “We are delighted Serge is joining us during this transformative time in PCI’s growth. His appointment is significant; confirming our long-standing commitment to partnering with leading pharmaceutical and biotech companies and help bring their life-saving medicines to patients around the world. Our trusted relationships with our customers are at the heart of all we do; our strategic growth plan, backed by robust global investment, reflects this. Serge will play an invaluable role as we build new capabilities and capacity, supported by innovative technology and first-class equipment – ensuring PCI continues to deliver outstanding quality and service for our clients in both established and emerging global markets.”

Serge added: “I am excited to join the PCI organization, a very successful and unique leader in the pharmaceutical and biotech industry. I believe that PCI is very well-positioned and has a tremendous growth potential based on the impressive reputation, depth of knowledge and sizeable investment.”

PCI recently expanded operations through acquisition, adding key locations in San Diego, Dublin and Melbourne, as well as announcing a record year for capital investment across its global business.

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40